167 related articles for article (PubMed ID: 15605110)
1. The corticotropin-releasing factor system as a potential target for antiobesity drugs.
Doyon C; Moraru A; Richard D
Drug News Perspect; 2004 Oct; 17(8):505-17. PubMed ID: 15605110
[TBL] [Abstract][Full Text] [Related]
2. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance.
Richard D; Lin Q; Timofeeva E
Eur J Pharmacol; 2002 Apr; 440(2-3):189-97. PubMed ID: 12007535
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
Pelleymounter MA; Joppa M; Ling N; Foster AC
J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
[TBL] [Abstract][Full Text] [Related]
4. Cross species association examination of UCN3 and CRHR2 as potential pharmacological targets for antiobesity drugs.
Jiang Z; Michal JJ; Williams GA; Daniels TF; Kunej T
PLoS One; 2006 Dec; 1(1):e80. PubMed ID: 17183713
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor receptor signaling and modulation: implications for stress response and resilience.
Vasconcelos M; Stein DJ; Gallas-Lopes M; Landau L; de Almeida RMM
Trends Psychiatry Psychother; 2020 Jun; 42(2):195-206. PubMed ID: 32696892
[TBL] [Abstract][Full Text] [Related]
6. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment.
Stout SC; Owens MJ; Nemeroff CB
J Pharmacol Exp Ther; 2002 Mar; 300(3):1085-92. PubMed ID: 11861819
[TBL] [Abstract][Full Text] [Related]
7. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.
Owens MJ; Vargas MA; Nemeroff CB
J Psychiatr Res; 1993; 27 Suppl 1():209-20. PubMed ID: 8145178
[TBL] [Abstract][Full Text] [Related]
8. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
9. Localization and physiological roles of urocortin.
Oki Y; Sasano H
Peptides; 2004 Oct; 25(10):1745-9. PubMed ID: 15476941
[TBL] [Abstract][Full Text] [Related]
10. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats.
Sarnyai Z; Bíró E; Penke B; Telegdy G
Brain Res; 1992 Aug; 589(1):154-6. PubMed ID: 1330207
[TBL] [Abstract][Full Text] [Related]
11. The role of corticotropin-releasing factor in depression and anxiety disorders.
Arborelius L; Owens MJ; Plotsky PM; Nemeroff CB
J Endocrinol; 1999 Jan; 160(1):1-12. PubMed ID: 9854171
[TBL] [Abstract][Full Text] [Related]
12. Progress in corticotropin-releasing factor-1 antagonist development.
Zorrilla EP; Koob GF
Drug Discov Today; 2010 May; 15(9-10):371-83. PubMed ID: 20206287
[TBL] [Abstract][Full Text] [Related]
13. Key role of CRF in the skin stress response system.
Slominski AT; Zmijewski MA; Zbytek B; Tobin DJ; Theoharides TC; Rivier J
Endocr Rev; 2013 Dec; 34(6):827-84. PubMed ID: 23939821
[TBL] [Abstract][Full Text] [Related]
14. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
[TBL] [Abstract][Full Text] [Related]
15. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
16. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors.
Suda T; Kageyama K; Sakihara S; Nigawara T
Peptides; 2004 Oct; 25(10):1689-701. PubMed ID: 15476936
[TBL] [Abstract][Full Text] [Related]
17. Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition.
Reis FM; Fadalti M; Florio P; Petraglia F
J Soc Gynecol Investig; 1999; 6(3):109-19. PubMed ID: 10376266
[TBL] [Abstract][Full Text] [Related]
18. The roles of corticotropin-releasing factor-related peptides and their receptors in the cardiovascular system.
Nazarloo HP; Buttrick PM; Saadat H; Dunn AJ
Curr Protein Pept Sci; 2006 Jun; 7(3):229-39. PubMed ID: 16787262
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
20. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
